Intrinsic value of Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics, Inc. (TNGX) intrinsic value snapshot: our valuation models currently suggest the stock is overvalued, with an estimated 209.0% downside relative to fair value at a market price of $25.47. Unlock the dollar fair value estimate for Tango Therapeutics, Inc. with Tickerplace Pro.

Intrinsic Value (Fair Value): Unlock fair value

Downside: -209.0%

Margin of Safety: Unlock fair value

Current Price: $25.47

Valuation: Overvalued

Confidence: 9.5/10

Visual Bar

Market Price $25.47Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

How we calculate fair value: We combine DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models to estimate intrinsic value. This figure is for information only - not investment advice - and assumptions may not reflect actual market conditions. We encourage doing your own research or speaking with a financial advisor before making investment decisions.

Intrinsic Value checker

Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.

Is Tango Therapeutics, Inc. (TNGX) undervalued or overvalued?

The verdict and fair-value gap for Tango Therapeutics, Inc. (TNGX) are summarised in the intrinsic value snapshot above. This section explains the method: we compare the live market price with modeled fair value using DCF, P/E Multiple, and P/S Multiple approaches. Assumptions can change with new earnings, growth, and discount-rate inputs, so treat the result as a research aid rather than a buy or sell signal. Tickerplace Pro unlocks the dollar fair value used in that comparison.

Fair value vs market price — Tango Therapeutics, Inc. (TNGX)

Use this section for context around the gap, not a third restatement of the top-line verdict. The free snapshot above already shows the percentage gap and market price; the dollar intrinsic value stays behind Tickerplace Pro. Compare TNGX with related intrinsic-value pages listed below (EYPT, KURA, NRIX, and more) to see how peers are framed on the same models.

Frequently Asked Questions - TNGX

What is the intrinsic value of Tango Therapeutics, Inc. (TNGX)?

Our models calculate the intrinsic value of Tango Therapeutics, Inc. (TNGX) using DCF, P/E Multiple, and P/S Multiple approaches based on projected cash flows, growth rate, and discount rate. Sign in to Tickerplace Pro to view the full dollar estimate.

Is TNGX undervalued or overvalued?

Based on our 2026 valuation models, TNGX appears overvalued at its current price of $25.47. Our model suggests the stock may be overvalued by 209.0%.

How is TNGX's intrinsic value calculated?

Tickerplace calculates TNGX's intrinsic value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We project future cash flows, apply a discount rate that reflects investment risk, and compare the resulting fair value estimate to the current market price.

Related companies — intrinsic value

Peers for TNGX: open their intrinsic value pages.

Explore Our Valuation Calculators